| Camidge, D. Ross; Tiseo, Marcello; Ahn, Myung-Ju; Reckamp, Karen; Hansen, Karin; Kim, Sang-We; Huber, Rudolf; West, Howard; Grön, Harry; Hochmair, Maximilian; Leighl, Natasha; Gettinger, Scott; Langer, Corey; Paz-Ares, Luis; Smit, Egbert; Kim, Edward; Reichmann, William; Clackson, Tim; Kerstein, David; Haluska, Frank; Kim, Dong-Wan (2017): Brigatinib in Crizotinib-Refractory ALK plus NSCLC: Central Assessment and Updates from ALTA, a Pivotal Randomized Phase 2 Trial. In: Journal of thoracic Oncology, Vol. 12, No. 1: S1167-S1169 |
Full text not available from 'Open Access LMU'.
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 1556-0864 |
| Language: | English |
| ID Code: | 51257 |
| Deposited On: | 14. Jun 2018 09:45 |
| Last Modified: | 14. Jun 2018 09:45 |
Repository Staff Only: item control page
